Esenbeckia leiocarpa Engl. inhibits inflammation in a carrageenan-induced murine model of pleurisy

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 8, 2011, Pages 1091-1102

  Pozzatti, Patrícia ^a   Dos Reis, Gustavo Oliveira ^a   Pereira, Danielle Fontana ^a   Heller, Melina ^b   Micke, Gustavo Amadeu ^b   Horst, Heros ^b   Pizzolatti, Moacir Geraldo ^b   Fröde, Tânia Silvia ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b Centre for Physical and Mathematical Sciences   (Brazil)

Author keywords

Adenosine deaminase; Anti inflammatory activity; Esenbeckia leiocarpa Engl.; Myeloperoxidase; Nitric oxide; Pro inflammatory cytokines

Indexed keywords

ACETIC ACID ETHYL ESTER; ADENOSINE DEAMINASE; ALKALOID; ALKALOID DERIVATIVE; ANTIINFLAMMATORY AGENT; DEXAMETHASONE; DIHYDROCORYNANTHEOL; ESENBECKIA LEIOCARPA EXTRACT; HEXANE; INDOMETACIN; INTERLEUKIN 1BETA; MYELOPEROXIDASE; NITRIC OXIDE; NITRITE; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BARK; CAPILLARY ELECTROPHORESIS; CARBON NUCLEAR MAGNETIC RESONANCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG RESEARCH; DRUG STRUCTURE; ESENBECKIA LEIOCARPA; FRACTIONATION; LEUKOCYTE MIGRATION INHIBITION; MASS SPECTROMETRY; MONONUCLEAR CELL; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PLEURA FLUID; PLEURISY; PROTON NUCLEAR MAGNETIC RESONANCE; RUTACEAE;

ALKALOIDS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; DISEASE MODELS, ANIMAL; INFLAMMATION; INFLAMMATION MEDIATORS; MICE; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS; PLEURISY; RUTACEAE;

EID: 79959885350     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01311.x     Document Type: Article

References (41)

1. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007; 70: 461-477. (Pubitemid 46595760)
2. Kaplan M et al. Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders. Complement Ther Med 2007; 15: 207-216. (Pubitemid 47250488)
3. Dreyer DL et al. Distribution of limonoids in the Rutaceae. Phytochemistry 1972; 11: 705-713.
4. Carvalho LH et al. Antimalarial activity of crude extracts from Brazilian plants studied in vivo in Plasmodium berghei-infected mice and in vitro against Palsmodium falciparum in culture. Braz J Med Biol Res 1991; 24: 1113-1123.
5. Dolabela MF et al. In vitro antiplasmodial activity of extract and constituents from Esenbeckia febrifuga, a plant traditionally used to treat malaria in the Brazilian Amazon. Phytomedicine 2008; 15: 367-372.
6. Napolitano HB et al. Aurapten, a coumarin with growth inhibition against Leishmania major promastigotes. Braz J Med Biol Res 2004; 37: 1847-1852. (Pubitemid 40089938)
7. Aguilar-Guadarrama AB, Rios MY. Geranyl Ndimethylallylanthranilate, a new compound from Esenbeckia yaaxhokob. Planta Med 2004; 70: 85-86.
8. Dreyer DL. Alkaloids, limonoids and furocoumarins from three Mexican Esenbeckia species. Phytochemistry 1980; 19: 941-944.
9. Delle Monache F et al. Isopentenylindole derivatives and other components of Esenbeckia leiocarpa. Gazz Chim Ital 1989; 119: 435-439.
10. Nakatsu T et al. Isolation, structure, and synthesis of novel 4-quinolinone alkaloids from Esenbeckia leiocarpa. J Nat Prod 1990; 53: 1508-1513.
11. Oliveira FM et al. Alkaloids and coumarins from Esenbeckia species. Phytochemistry 1996; 41: 647-649.
12. Rios MY, Delgado G. Furocoumarins, terpenes and sterols from Esenbeckia ovata Kunth (Rutaceae). Biochem Syst Ecol 2002; 30: 697-699. (Pubitemid 34764374)
13. Trani M et al. Dihydrochalcones and coumarins of Esenbeckia grandiflora subsp. brevipetiolata. Fitoterapia 2004; 75: 99-102. (Pubitemid 38010415)
14. Mata R et al. Phytotoxic compounds from Esenbeckia yaxhoob. Phytochemistry 1998; 49: 441-447.
15. Kubo I. Recent applications of counter-current chromatography to the isolation of bioactive natural products. J Chromatogr 1991; 538: 187-191.
16. Chen YF et al. Anti-inflammatory and analgesic activities from roots of Angelica pubescens. Planta Med 1995; 61: 2-8.
17. Ban HS et al. Inhibitory effects of furanocoumarins isolated from the roots of Angelica dahurica on prostaglandin E2 production. Planta Med 2003; 69: 408-412. (Pubitemid 36774179)
18. Adams M et al. Inhibition of leukotriene biosynthesis by quinolone alkaloids from the fruits of Evodia rutaecarpa. Planta Med 2004; 70: 904-908. (Pubitemid 39457798)
19. Kim JS et al. Chemical constituents of the root of Dystaenia takeshimana and their anti-inflammatory activity. Arch Pharm Res 2006; 29: 617-623. (Pubitemid 44338458)
20. Xie F et al. Anti-inflammatory and analgesic activities of ethanolic extract and two limonoids from Melia toosendan fruit. J Ethnopharmacol 2008; 117: 463-466.
21. Hsu CL et al. Antioxidant and anti-inflammatory effects of Orthosiphon aristatus and its bioactive compounds. J Agric Food Chem 2010; 58: 2150-2156.
22. Yi T et al. Comparison of the anti-inflammatory and antinociceptive effects of three medicinal plants known as 'Snow Lotus' herb in traditional Uighur and Tibetan medicines. J Ethnopharmacol 2010; 128: 405-411.
23. Taveira JJ et al. Indole alkaloids from Aspidosperma pruinosum. Phytochemistry 1992; 31: 2507-2511.
24. Saleh TSF et al. Anti-inflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy. Br J Pharmacol 1996; 118: 811-819. (Pubitemid 26180999)
25. Sawyer I et al. The vasoactive potential of kisspeptin-10 in the peripheral vasculature. PLoS ONE 2011; 6: e14671.
26. Moitra J et al. Re-evaluation of Evans blue dye as a marker of albumin clearance in murine models of acute lung injury. Transl Res 2007; 150: 253-265. (Pubitemid 47444609)
27. Green IC et al. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
28. Giusti G, Galanti B. Adenosine deaminase: colorimetric method. In: Bergmeyer HU, ed. Methods of Enzymatic Analyses. Weinheim: Verlang Chemie Press, 1984: 315-323.
29. Rao TS et al. Comparative evaluation of arachidonic acid (AA) and tetracanoylphorbol acetate (TPA) induced dermal inflammation. Inflammation 1993; 17: 723-741. (Pubitemid 23359094)
30. Blackburn MR, Kellems RE. Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation. Adv Immunol 2005; 86: 1-41. (Pubitemid 40215689)
31. Arnhold J, Flemmig J. Human myeloperoxidase in innate and acquired immunity. Arch Biochem Biophys 2010; 500: 92-106.
32. Fröde TS, Medeiros YS. Myeloperoxidase and adenosinedeaminase levels in the pleural fluid leakage induced by carrageenan in the mouse model of pleurisy. Mediators Inflamm 2001; 10: 223-227. (Pubitemid 32846112)
33. Tripathi P et al. The role of nitric oxide in inflammation reactions. FEMS Immunol Med Microbiol 2007; 51: 443-452. (Pubitemid 350076162)
34. Nagy G et al. Nitric oxide, chronic inflammation and autoimmunity. Immunol Lett 2007; 111: 1-5. (Pubitemid 47017476)
35. Bradley JRTN. F-mediated inflammatory disease. J Pathol 2008; 214: 149-160.
36. Gabay C et al. IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol 2010; 6: 232-241.
37. Van Der Veen BS et al. Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal 2009; 11: 1-39.
38. Abramson SB. Nitric oxide in inflammation and pain associated with osteoarthritis. Arthritis Res Ther 2008; 10(Suppl. 2): 1-7.
39. Laragione T et al. The arthritis severity quantitative trait loci Cia4 and Cia6 regulate neutrophil migration into inflammatory sites and levels of TNF-alpha and nitric oxide. J Immunol 2007; 178: 2344-2351. (Pubitemid 46233433)
40. Oliveira SHP et al. Neutrophil migration induced by IL-1beta depends upon LTB4 released by macrophages and upon TNFalpha and IL-1beta released by mast cells. Inflammation 2008; 31: 36-46. (Pubitemid 351246254)
41. Olajide OA et al. Anti-inflammatory properties of cryptolepine. Phytother Res 2009; 23: 1421-1425.